Zobrazeno 1 - 10
of 162
pro vyhledávání: '"E L, Luchikhina"'
Autor:
D. E. Karateev, E. L. Luchikhina
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 0, Pp 51-67 (2020)
This systematic review focuses on the state-of-the-art pharmacotherapy of immune disorders in the novel coronavirus infection (COVID-19), leading to a cytokine storm and uncontrolled inflammatory response that causes severe tissue damage and multiple
Externí odkaz:
https://doaj.org/article/8370af0b97f0434a83de3b11eb2120f3
Autor:
A. V. Molochkov, D. E. Karateev, E. Yu. Ogneva, A. B. Zulkarnaev, E. L. Luchikhina, I. V. Makarova, D. Yu. Semenov
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 48, Iss 0, Pp 1-10 (2020)
Background: The COVID-19 pandemic is seriously affecting the society and economy of many countries, including the Russian Federation. Identifying of the major risk factors for an unfavorable outcome could help save lives and reduce the disease burden
Externí odkaz:
https://doaj.org/article/c642bb1b62624474a417f29691a63dca
Autor:
A. M. Satybaldyev, N. V. Demidova, G. I. Gridneva, N. Yu. Nikishina, E. V. Gerasimova, D. A. Gukasian, K. A. Kasumova, E. L. Luchikhina, A. S. Misiyuk, T. G. Oskilko, O. A. Rumyantseva, E. A. Zlepko, L. N. Tyurina, E. V. Fedorenko, N. V. Shornikova, E. L. Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 58, Iss 2, Pp 140-146 (2020)
The paper presents three cohorts of patients with early rheumatoid arthritis (RA) who fell ill at 50 years or older and had a disease duration of 1.5 months to 1 year. To establish its diagnosis, the investigators used classification criteria for eac
Externí odkaz:
https://doaj.org/article/f2fba16abc364e1db86601fe3e792f2d
Autor:
D. E. Karateev, E. L. Luchikhina
Publikováno v:
Медицинский совет, Vol 0, Iss 2, Pp 83-94 (2020)
The treatment of immuno-inflammatory rheumatic diseases has advanced significantly in recent decades due to development of biological medications, which, however, are not without some weak points. They include immunogenicity, parenteral administratio
Externí odkaz:
https://doaj.org/article/d436f289fd624aaa83673aaf04eef7cd
Autor:
D. E. Karateev, E. L. Luchikhina
Publikováno v:
Медицинский совет, Vol 0, Iss 18, Pp 85-91 (2019)
Despite progress in pharmacotherapy, there still are urgent needs in the development of new methods of drug therapy of rheumatoid arthritis (RA). New prospects for drug therapy are currently associated with sarilumab (SAR), recently registered in the
Externí odkaz:
https://doaj.org/article/f032542d9f5348adb7ad4fecc5b40f4e
Autor:
D. E. Karateev, E. L. Luchikhina
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 5, Pp 461-469 (2019)
Rheumatoid arthritis (RA) is one of the most prevalent autoimmune diseases in humans and is a serious medical and social problem in the Russian Federation. Current synthetic and biological agents acting through specific molecular targets, play a sign
Externí odkaz:
https://doaj.org/article/49285db5fd564f96835b462de5ca8922
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 47, Iss 5, Pp 383-392 (2019)
Background: Methotrexate is the main synthetic disease-modifying antirheumatic drug for the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA) and other immunoinflammatory conditions. In the recent years, the subcutaneous form of metho
Externí odkaz:
https://doaj.org/article/f5ce7276f303482b8e448dba529a6373
Autor:
E. V. Udachkina, D. S. Novikova, T. V. Popkova, I. G. Kirillova, E. I. Markelova, Yu. N. Gorbunova, D. E. Karateev, E. L. Luchikhina, N. V. Demidova, M. A. Borisova, G. V. Lukina, S. I. Glukhova, A. V. Volkov
Publikováno v:
Научно-практическая ревматология, Vol 56, Iss 4, Pp 449-455 (2018)
Rheumatoid arthritis (RA) is a disease with a high cardiovascular risk. The results of works on the impact of antirheumatic therapy on carotid artery (CA) intima-media thickness (IMT) are contradictory. Objective: to assess the time course of changes
Externí odkaz:
https://doaj.org/article/91c02c5ffd164a379cb6be690fcd330d
Autor:
I. G. Kirillova, D. S. Novikova, T. V. Popkova, E. V. Udachkina, E. I. Markelova, A. A. Novikov, Yu. N. Gorbunova, A. V. Volkov, E. L. Luchikhina, N. V. Demidova, M. A. Borisova, G. V. Lukina
Publikováno v:
Научно-практическая ревматология, Vol 56, Iss 3, Pp 328-332 (2018)
Objective: to investigate the impact of antirheumatic therapy carried out according to the treat-to-target (T2T) principle on the time course of changes in NT-proBNP levels in patients with early rheumatoid arthritis (RA) over an 18- month follow-up
Externí odkaz:
https://doaj.org/article/05114a36761c4c3b94a5e4048f24c465
Autor:
I A Guseva, A V Smirnov, N V Demidova, M Yu Krylov, A S Avdeeva, E Yu Samarkina, E L Luchikhina, D E Karateev, D D Abramov, E L Nasonov
Publikováno v:
Терапевтический архив, Vol 90, Iss 5, Pp 38-43 (2018)
Objective. To clarify the association between HLA-DRB1 and TNFα (-308G>A) genes polymorphism and joint destruction/further progression during 12 months of the follow-up period (FUP) in patients with early (
Externí odkaz:
https://doaj.org/article/485938261a6c458aa6c7809045487b63